Dr. Z wants to share this article from:
San Diego — Officials of Cytori Therapeutics, based here, say British surgeons have successfully used the company’s adipose-derived regenerative cell (ADRC) fat grafting procedure — which the company calls RESTORE — in reconstructive breast surgery, Medical News Today reports.
The company says clinical outcomes were reported at the Association of Breast Surgery Conference in Manchester, England, earlier this month. The procedure was separately investigated in Cytori's own RESTORE 2 trial, according to Medical News Today.
The British surgeons’ report results from an independent, prospective study of 23 patients who received ADRC-enhanced fat grafting for the correction of breast-contour defects following cancer treatment or benign conditions including implant complications, using Cytori’s Celution System. Patients were treated between September 2008 and November 2010 with follow-up between three months and two years. The results showed that 19 of the patients, or 82 percent, reported good to excellent results, with a mean satisfaction score of 5.1 (1 being worst, 6 being best).
The results further showed a high level of investigator satisfaction, with a mean satisfaction score of 4.3. Study findings demonstrated a low complication rate.
Overall, the company says, the study results suggest the RESTORE procedure is a viable breast reconstruction option.
Cosmetic Surgery Times E-News
If you are selecting from among the many Las Vegas plastic surgeons, they are confident they can help you achieve the results you desire.
ReplyDeletebrow lift las vegas